Result 3 - Prosorba, Rituxan, Splenectomy, Vinca Alkaloids

Selected Treatment Results



PROSORBA* 1.42%   RITUXAN 3.28%   SPLENECTOMY 35.63%   VINCA ALKALOIDS 9.40%
 Platelets      Platelets      Platelets      Platelets  
  › Some 53.85%     › Some 60.00%     › Some 69.63%     › Some 54.65%
  › Sustained 30.77%     › Sustained 13.33%     › Sustained 40.80%     › Sustained 10.47%
 Bleeding      Bleeding      Bleeding      Bleeding  
  › Some 61.54%     › Some 53.33%     › Some 65.44%     › Some 48.28%
  › Normal 23.08%     › Normal 10.00%     › Normal 39.76%     › Normal 16.09%
 Side Effects      Side Effects      Side Effects      Side Effects  
  › Some 53.85%     › Some 53.33%     › Some 43.56%     › Some 75.58%
  › Severe 7.69%     › Severe 3.33%     › Severe 4.91%     › Severe 26.74%
                     


* NOTE: The Prosorba Column is no longer recommended for the treatment of ITP.

Learn More about the Treatments in This Survey

 

back to top

ITP HelpLine logo

You’re not alone. We have answers!
Contact PDSA to connect with life altering information, resources and referrals.
877.528.3538 or PDSA@PDSA.org

BBB Cleveland logo GuideStar Seal NORD Member Badge 2018THSNA logo